Kaigene has signed this exclusive licensing arrangement with Taisho Pharmaceutical, kind of to help build and then commercialize its next-generation autoimmune treatment KG006, specifically in Japan. So basically under the…
Sysmex Corporation and Gaudi Clinical Inc., have signed an agreement. This agreement…
Fujirebio Holdings Inc., its wholly-owned subsidiary Fujirebio Diagnostics, Inc., and AriBio Co.,…
Asada Ladies Clinic and IBM Japan announced that they had jointly developed…
Amplat Inc. is pleased to announce that it has begun a collaboration…
Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop…
Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and…
AGC Biologics, your friendly CDMO expert, announced a multiphase partnership with Novelty…
Nikon CeLL Innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation, has…
Sysmex Corporation and Gaudi Clinical Inc., have signed an agreement. This agreement…
Fujirebio Holdings Inc., its wholly-owned subsidiary Fujirebio Diagnostics, Inc., and AriBio Co.,…
Asada Ladies Clinic and IBM Japan announced that they had jointly developed…
Amplat Inc. is pleased to announce that it has begun a collaboration…
Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop…
Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and…
AGC Biologics, your friendly CDMO expert, announced a multiphase partnership with Novelty…
Nikon CeLL Innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation, has…
Sign in to your account